Is There an Association Between Diabetic Neuropathy and Low Vitamin D Levels?

Current Diabetes Reports

Volumn 14, Issue 10, 2014, Pages

  Putz, Zsuzsanna ^a   Martos, Tímea ^a   Németh, Nóra ^a   Körei, Anna Erzsébet ^a   Vági, Orsolya Erzsébet ^a   Kempler, Miklós Soma ^a   Kempler, Péter ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Diabetes mellitus; Neuropathy; Vitamin D

Indexed keywords

HEMOGLOBIN A1C; NERVE GROWTH FACTOR; VITAMIN D; VITAMIN D RECEPTOR;

CARDIOVASCULAR RISK; DIABETIC NEUROPATHY; DIABETIC PATIENT; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; NEUROPATHIC PAIN; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PLANTAR ULCER; REVIEW; SENSORY NERVE CELL; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN D METABOLISM; VITAMIN SUPPLEMENTATION; BONE DENSITY; COMPLICATION; DIABETIC NEUROPATHIES; INCIDENCE; METABOLISM; PATHOPHYSIOLOGY; PUBLIC HEALTH; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; SEVERITY OF ILLNESS INDEX;

BONE DENSITY; DIABETES MELLITUS, TYPE 2; DIABETIC NEUROPATHIES; HUMANS; INCIDENCE; PUBLIC HEALTH; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; SEVERITY OF ILLNESS INDEX; VITAMIN D DEFICIENCY;

EID: 84919455785     PISSN: 15344827     EISSN: 15390829     Source Type: Journal    
DOI: 10.1007/s11892-014-0537-6     Document Type: Review

References (37)

1. Chowdhury R, Kunutsor S, Vitezova A, Oliver-Williams C, Chowdhury S, Kiefte-de-Jong JC, et al. Vitamin D and risk of cause specific death: systematic review and meta-analysis of observational cohort and randomised intervention studies. BMJ. 2014;348:g1903.
2. International Diabetes Federation. IDF Diabetes Atlas 6th edn. Brussels: International Diabetes Federation; 2013.
3. Wolden-Kirk H, Rondas D, Bugliani M, Korf H, Van Lommel L, Brusgaard K, et al. Discovery of molecular pathways mediating 1,25-dihydroxyvitamin D3 protection against cytokine-induced inflammation and damage of human and male mouse islets of Langerhans. Endocrinology. 2014;155(3):736–47.
4. Raab J, Giannopoulou EZ, Schneider S, Warncke K, Krasmann M, Winkler C, et al. Prevalence of vitamin D deficiency in pre-type 1 diabetes and its association with disease progression. Diabetologia. 2014;57(5):902–8.
5. Scragg R, Sowers M, Bell C. Third National Health and Nutrition Examination Survey, serum 25-hydroxyvitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey. Diabetes Care. 2004;27(12):2813–8.
6. Putz Z, Hermányi Z, Tóth N, Istenes I, Keresztes K, Jermendy G, et al. A distalis típusú, sensoros neuropathia diagnosztikája a diabetológiai gyakorlatban. Diabetologia Hungarica. 2008;16:157–64.
7. Zs P, Kempler P, Jermendy G. Diabetes specifikus szövődmények prediabetesben. Orv Hetil. 2009;150(47):2139–45.
8. Ziegler D. Diabetic cardiovascular autonomic neuropathy: prognosis, diagnosis and treatment. Diabetes Metab Rev. 1994;10(4):339–83.
9. Eyles DW, Smith S, Kinobe R, Hewison M, McGrath JJ. Distribution of the vitamin D receptor and 1 alpha-hydroxylase in human brain. J Chem Neuroanat. 2005;29:21–30.
10. Freedman DM, Dosemeci M, Alavanja MC. Mortality from multiple sclerosis and exposure to residential and occupational solar radiation: a case–control study based on death certificates. Occup Environ Me. 2000;57:418–21.
11. Munger KL, Levin LI, Hollis BW, Howard NS, Ascherio A. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA. 2006;296:2832–8.
12. van der Mei IA, Ponsonby AL, Dwyer T, Blizzard L, Taylor BV, Kilpatrick T, et al. Vitamin D levels in people with multiple sclerosis and community controls in Tasmania, Australia. J Neurol. 2007;254:581–90.
13. Simpson Jr S, Taylor B, Blizzard L, Ponsonby AL, Pittas F, Tremlett H, et al. I., Higher 25-hydroxyvitamin D is associated with lower relapse risk in multiple sclerosis. Ann Neurol. 2010;68:193–203.
14. Soilu-Hänninen M, Laaksonen M, Laitinen I, Erälinna JP, Lilius EM, Mononen I. A longitudinal study of serum 25-hydroxyvitamin D and intact parathyroid hormone levels indicate the importance of vitamin D and calcium homeostasis regulation in multiple sclerosis. J Neurol Neurosurg Psychiatry. 2008;79:152–7.
15. Mowry EM, Krupp LB, Milazzo M, Chabas D, Strober JB, Belman AL, et al. Vitamin D status is associated with relapse rate in pediatric-onset multiple sclerosis. Ann Neurol. 2010;67:618–24.
16. Correale J, Ysrraelit MC, Gaitán MI. Immunmodulatory effects of vitamin D in multiple sclerosis. Brain. 2009;132:1146–60.
17. Burton JM, Kimball S, Vieth R, Bar-Or A, Dosch HM, Cheung R, et al. A phase I/II doseescalation trial of vitamin D3 and calcium in multiple sclerosis. Neurology. 2010;74:1852–9.
18. Smolders J, Hupperts R, Barkhof F, Grimaldi LM, Holmoy T, Killestein J, et al. Efficacy of vitamin D(3) as add-on therapy in patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon beta-1a: a Phase II, multicenter, double-blind, randomized, placebo-controlled trial. J Neurol Sci. 2011;311:44–9.
19. Llewellyn DJ, Lang IA, Langa KM, Muniz-Terrera G, Phillips CL, Cherubini A, et al. Vitamin D and risk of cognitive decline in elderly persons. Arch Intern Med. 2010;170(13):1135–41.
20. Knekt P, Kilkkinen A, Rissanen H, Marniemi J, Sääksjärvi K, Heliövaara M. Serum vitamin D and the risk of Parkinson disease. Arch Neurol. 2010;67(7):808–11.
21. Ding H, Dhima K, Lockhart KC, Locascio JJ, Hoesing AN, Duong K, et al. Unrecognized vitamin D3 deficiency is common in Parkinson disease: Harvard Biomarker Study. Neurology. 2013;81(17):1531–7.
22. Lee P, Chen R. Vitamin D as an analgesic for patients with type 2 diabetes and neuropathic pain. Arch Intern Med. 2008;168:771–2.
23. Shebab D, Al-Jarallah K, Mojiminiyi OA, Al Mohamedy H, Abdella NA. Does vitamin D deficiency play a role in peripheral neuropathy in type 2 diabetes? Diabet Med. 2012;29:43–9.
24. Valensi P, Devehat C, Richard JL, Farez C, Khodabandehlou T, Rosenbloom RA, et al. A multicenter double blind, safety study of QR-333 for treatment of symptomatic diabetic peripheral neuropathy: a preliminary report. J Diabetes Complicat. 2005;19:247–53.
25. Soderstrom LH, Johnson SP, Diaz VA, Mainous 3rd AG. Association between vitamin D and diabetic neuropathy in a nationally reperesentative sample: results from 2001–2004 NHANES. Diabet Med. 2012;29:50–5. This study analyses a representative sample, proving that Vitamin D is insufficiency associated with self-reported peripheral neuropathy symptoms.
26. Skalli S, Muller M, Pradines S, Halimi S, Wion-Barbot N. Vitamin D deficiency and peripheral diabetic neuropathy. Eur J Intern Med. 2012;23:67–8.
27. Ahmadieh H, Azar ST, Lakkis N, Arabi A. Hypovitaminosis D in patients with type 2 diabetes mellitus: a relation to disease control and complications. ISRN Endocrinol. 2013;22(2013):641098.
28. Riaz S, Malcangio M, Miller M, Tomlinson DR. A vitamin D3 derivative (CB1093) induces nerve growth factor and prevents neurothrophic deficits in streptozotocin-diabetic rats. Diabetologia. 1999;42:1308–13.
29. Riaz S, Tomlinson DR. Pharmacological modulation of nerve growth factor synthesis: a mechanistic comparison of vitamin D receptor and beta(2)-adrenoreceptor agonists. Brain Res Mol. 2000;85:179–88.
30. Filipović N, Ferhatović L, Marelja I, Puljak L, Grković I. Increased vitamin D receptor expression in dorsal root ganglia neurons of diabetic rats. Neurosci Lett. 2013;9(549):140–5.
31. Plotnikoff GA, Quigley JM. Prevalence of severe hypovitaminosis D in patients with persistent, nonspecific musculosceletal pain. Mayo Clin Proc. 2003;78:1463–70.
32. Bell DSH, Reversal of the symptoms of diabetic neuropathy through correction of vitamin D deficiency in a type 1 diabetic patient. Case Report in Endocrinology, 2012: p. 1–3.
33. Bell DSH. Protean manifestations of vitamin D deficiency, part 2: deficiency and its association with autotoimmune disease, cancer, infection, asthma, dermopathies, insulin resistance, and type 2 diabetes. South Med J. 2011;335–339:335–9.
34. Van Etten E, Branisteanu DD, Verstuyf A, Waer M, Bouillon R, Mathieu C. Analogs of 1,25-dihydroxyvitamin D3 as dose-reducing agents for classical immunosuppressants. Transplantation. 2000;69:1932–42.
35. Zubair M, Malik A, Meerza D, Ahmad J. 25-hydroxyvitamin D [25(OH)D] levels and diabetic foot ulcer: is there any relationship? Diabetes Metab Synd. 2013;7:148–53. Diabetic foot ulcer is a burden for the developed industrial countries, nearly half of all lower-leg amputations of a non-traumatic origin are performed on patients with diabetes. Vitamin D have a possible effect in decreasing this huge number.
36. Hutchinson MS, Figenschau Y, Njølstad I, Schirmer H, Jorde R. Serum 25-hydroxyvitamin D levels are inversely associated with glycated haemoglobin (HbA(1c)). The Tromsø Study. Scand J Clin Lab Invest. 2011;71(5):399–406.
37. Zoppini G, Galletti A, Targher G, Brangani C, Pichiri I, Negri C, et al. Glycated haemoglobin is inversely related to serum vitamin D levels in type 2 diabetic patients. PLoS One. 2013;8(12):e82733.